Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2005
11/15/2005US6965016 Antagonist for use in the prevention of fertility in humans and animals
11/15/2005US6965015 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/15/2005US6965014 Bioerodible film; mixture of thrombin and fibrinogen; controlling coagulation; drug delivery of antitumor, anticancer agents
11/15/2005US6965013 binds to the calcitonin receptor-like receptor and activates the receptor upon binding.
11/15/2005US6965012 Flint polypeptide analogs
11/15/2005US6965011 Identification and characterization of extracellular polypeptides having homology to EGF
11/15/2005US6965010 Polypeptideeptide for use in the treatment of cancer, neovascularization defects, retinopathies, arthritis and psoraisis
11/15/2005US6965009 p53 as protein and antibody therefor
11/15/2005US6964948 Therapeutic peptide-based constructs derived from Domain II of bactericidal/permeability-increasing protein
11/15/2005US6964868 Human polynucleotides; genetic engineering
11/15/2005US6964861 Enhanced in vitro recombinational cloning of using ribosomal proteins
11/15/2005US6964855 Peptides for detection to Anaplasma phagocytophilum
11/15/2005US6964853 Smad6 and uses thereof
11/15/2005US6964852 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
11/15/2005US6964851 Peptide for use in the treatment of hypertension, cancer, ischemia, trauma, infection inflammation, fever, heart and nervous system disorders
11/15/2005US6964849 Proteins and nucleic acids encoding same
11/15/2005US6964770 Recombinant plasmid and a method of controlling the effects of Yersinia pestis
11/15/2005US6964769 Molecular antigen array
11/15/2005US6964768 Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents
11/15/2005US6964767 Polypeptides; detecting infections using antibodies
11/15/2005US6964766 Peptides for use in immunotherapy of autoimmune diseases
11/15/2005US6964765 Hybrid nucleic acid; isolation antibody
11/15/2005US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector
11/15/2005US6964760 Lantibiotics for treatment and prevention of bacterial infections; useful in antimicrobial or antiseptic dentifrice
11/15/2005US6964199 Methods and compositions for enhanced protein expression and/or growth of cultured cells using co-transcription of a Bcl2 encoding nucleic acid
11/15/2005CA2182315C Expression of heterologous proteins in attenuated bacteria using the htra-promoters
11/14/2005CA2810292A1 Ligand for g-protein coupled receptor fprl2 and uses thereof
11/10/2005WO2005106495A1 Procollagen ii biomarkers and methods
11/10/2005WO2005106492A2 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 3 (ccr3)
11/10/2005WO2005106473A1 Method of screening therapeutic agent for neurodegenerative disease
11/10/2005WO2005106019A1 Granulin-epithelin precursor (gep) overexpression as a target for diagnosis, prognosis and treatment of hepatocellular carcinoma (hcc)
11/10/2005WO2005106009A2 Lactoferrin cleavage of neisserial proteins
11/10/2005WO2005106001A1 Methods and compositions for plant transformation
11/10/2005WO2005105997A1 Connexin 40 tissue specific gene mutations
11/10/2005WO2005105996A1 A pax-encoding vector and use thereof
11/10/2005WO2005105993A1 Hla-binding peptide, precursor thereof, dna fragment encoding the same and recombinant vector
11/10/2005WO2005105983A1 Use of the aca glycoprotein for obtaining/maintaining pluripotent non-embryonic stem cells
11/10/2005WO2005105850A1 Double brilliance beta-arrestin: a biosensor for monitoring the activity of receptors and signalling molecules, and method of using same
11/10/2005WO2005105843A2 Hiv protease inhibitors
11/10/2005WO2005105842A2 Crystal structure of cytochrome p450 3a4 and uses thereof
11/10/2005WO2005105841A2 Human g-protein chemokine receptor (ccr5) hdgnr10
11/10/2005WO2005105840A2 Cd40 variants and uses thereof
11/10/2005WO2005105839A2 Essential tremor diagnostic and treatment
11/10/2005WO2005105838A2 Ion channel
11/10/2005WO2005105837A2 Use of the ribosomal protein rpl41 to treat infections and inhibit cancer
11/10/2005WO2005105836A2 Methods and materials for improving plant drought tolerance
11/10/2005WO2005105835A1 A protein involved in cancer
11/10/2005WO2005105834A1 Method for the production of empty viral capsids in yeasts, said capsids comprising proteins derived from pvp2 of the virus that causes infectious bursal disease (ibdv)
11/10/2005WO2005105833A2 Novel herpes simplex viruses and uses thereof
11/10/2005WO2005105832A2 Biologically active peptide vapeehptllteaplnpk derivatives
11/10/2005WO2005105831A1 Antimicrobial polypeptides
11/10/2005WO2005105830A1 Interleukin-1 receptor antagonists, compositions, and methods of treatment
11/10/2005WO2005105829A2 Caspase-2 inhibitors and their biological applications
11/10/2005WO2005105138A2 Collagen mimics
11/10/2005WO2005105136A1 Nanogene therapy for cell proliferation disorders
11/10/2005WO2005105131A1 Modulation of cartilage homeostasis
11/10/2005WO2005104836A2 Drosophila models for diseases affecting learning and memory
11/10/2005WO2005104834A2 Pain-associated gene pnpg5
11/10/2005WO2005104823A2 Shade responsive promoter, promoter control elements, and combinations and uses thereof
11/10/2005WO2005104810A2 Novel therapeutic targets in cancer
11/10/2005WO2005087810A3 Dimeric fusion proteins and materials and methods for producing them
11/10/2005WO2005085860A3 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis
11/10/2005WO2005082932A3 Compositions and methods using rna interference for control of nematodes in plants
11/10/2005WO2005077975A3 Polypeptides comprising the pleckstrin homology domain of ect2 and their binding specificities to phosphatidylinositols
11/10/2005WO2005075684A3 Use of organic anion transporter b in screens for candidate substrates for crossing the blood brain barrier
11/10/2005WO2005068645A3 Anticariogenic proteins & peptides & saccharides
11/10/2005WO2005066348A3 Interleukin-12 targeted to oncofoetal fibronectin
11/10/2005WO2005051327A3 Glycopegylated erythropoietin
11/10/2005WO2005049075A3 Compositions and methods for the treatment of tumor of hematopoietic origin
11/10/2005WO2005047322A3 Factor viii compositions and methods
11/10/2005WO2005045044A3 Use of fibroblast growth factor fragments
11/10/2005WO2005041890A3 Erysipelothrix rhusiopathiae-haemophilus parasuis vaccine and methods of using the same
11/10/2005WO2005040418A3 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (r-spondins) and/or wnt
11/10/2005WO2005025592A3 In vivo modulation of neuronal transport
11/10/2005WO2005024058A3 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds
11/10/2005WO2005007691A8 East coast fever vaccine based on ctl-specific schizont antigens
11/10/2005WO2005001131A3 Methods for diagnosing mood disorders
11/10/2005WO2004113499A3 Modulation of flowering time by the pft1 locus
11/10/2005WO2004082640A8 Human serum albumin conjugates with therapeutic compounds
11/10/2005WO2004075842A3 Mrp3 genes and uses thereof
11/10/2005WO2004035743A3 Site specific incorporation of keto amino acids into proteins
11/10/2005WO2003106656A3 Single domain tdf-related compounds and analogs thereof
11/10/2005WO2003060098A3 Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna
11/10/2005WO2003029275A3 Anti-angiogenic peptides
11/10/2005US20050251880 Methods and compositions for regulating plant stress tolerance
11/10/2005US20050251878 DNA sequences from photorhabdus luminescens
11/10/2005US20050251870 Csnk1gs as modifiers of the p21 pathway and methods of use
11/10/2005US20050251869 Animal model for raising HDL-cholesterol with niacin
11/10/2005US20050250938 Isolated gamma coixin promoter comprising specified nucleic acid sequence
11/10/2005US20050250937 Nucleotide sequences coding enzymatic polypeptide for use in the generation of lysine
11/10/2005US20050250936 Modified TGF-beta superfamily proteins
11/10/2005US20050250935 New method for partition and inactivation of viral and prion contaminants
11/10/2005US20050250933 Vaccines
11/10/2005US20050250725 Regulation of the P21 gene and uses thereof
11/10/2005US20050250724 Methods for preventing or reducing ischemia/reperfusion induced myocardial cell death
11/10/2005US20050250720 Novel compound
11/10/2005US20050250717 Chromatin remodeling protein as a marker expressed by stromal progenitor cells
11/10/2005US20050250702 Controlling availability or activity of proteins by use of protease inhibitors or receptor fragments
11/10/2005US20050250700 KDR and VEGF/KDR binding peptides
11/10/2005US20050250699 Antimicrobial polypeptides
1 ... 1127 1128 1129 1130 1131 1132 1133 1134 1135 1136 1137 1138 1139 1140 1141 1142 1143 1144 1145 1146 1147 ... 2916